| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |